These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS. Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964 [TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. Higuchi T; Shimizu H; Fukuda T; Kawagoe S; Matsumoto J; Shimada Y; Kobayashi H; Ida H; Ohashi T; Morimoto H; Hirato T; Nishino K; Eto Y Mol Genet Metab; 2012 Sep; 107(1-2):122-8. PubMed ID: 22704483 [TBL] [Abstract][Full Text] [Related]
9. Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome. Arguello A; Meisner R; Thomsen ER; Nguyen HN; Ravi R; Simms J; Lo I; Speckart J; Holtzman J; Gill TM; Chan D; Cheng Y; Chiu CL; Dugas JC; Fang M; Lopez IA; Solanoy H; Tsogtbaatar B; Zhu Y; Bhalla A; Henne KR; Henry AG; Delucchi A; Costanzo S; Harris JM; Diaz D; Scearce-Levie K; Sanchez PE JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622797 [TBL] [Abstract][Full Text] [Related]
10. Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy. Ellison S; Liao A; Gleitz HFE; Parker H; Booth L; Robinson J; Wood S; Taylor J; Holley R; Bigger BW Mol Ther Methods Clin Dev; 2023 Dec; 31():101127. PubMed ID: 37920237 [TBL] [Abstract][Full Text] [Related]
11. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer. Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695 [TBL] [Abstract][Full Text] [Related]
12. Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy. Miwa S; Watabe AM; Shimada Y; Higuchi T; Kobayashi H; Fukuda T; Kato F; Ida H; Ohashi T Mol Genet Metab; 2020 Aug; 130(4):262-273. PubMed ID: 32631737 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients. Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880 [TBL] [Abstract][Full Text] [Related]
14. CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). Motas S; Haurigot V; Garcia M; Marcó S; Ribera A; Roca C; Sánchez X; Sánchez V; Molas M; Bertolin J; Maggioni L; León X; Ruberte J; Bosch F JCI Insight; 2016 Jun; 1(9):e86696. PubMed ID: 27699273 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO Yamamoto R; Kawashima S Nihon Yakurigaku Zasshi; 2022; 157(1):62-75. PubMed ID: 34980815 [TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase. Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110 [TBL] [Abstract][Full Text] [Related]
17. A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation. Mashima R; Ohira M; Okuyama T; Onodera M; Takada S Sci Rep; 2023 May; 13(1):7865. PubMed ID: 37188686 [TBL] [Abstract][Full Text] [Related]